nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP3A4—Imiquimod—skin cancer	0.157	0.233	CbGbCtD
Ciclesonide—CYP3A4—Temozolomide—skin cancer	0.157	0.233	CbGbCtD
Ciclesonide—CYP2D6—Vemurafenib—skin cancer	0.136	0.201	CbGbCtD
Ciclesonide—CYP3A4—Vismodegib—skin cancer	0.109	0.162	CbGbCtD
Ciclesonide—CYP3A4—Vemurafenib—skin cancer	0.0862	0.128	CbGbCtD
Ciclesonide—CYP3A4—Docetaxel—skin cancer	0.0296	0.0438	CbGbCtD
Ciclesonide—Musculoskeletal chest pain—Vismodegib—skin cancer	0.0178	0.057	CcSEcCtD
Ciclesonide—Hyperadrenocorticism—Temozolomide—skin cancer	0.0141	0.0451	CcSEcCtD
Ciclesonide—Fluocinonide—SMO—skin cancer	0.00872	1	CrCbGaD
Ciclesonide—Nasal discomfort—Fluorouracil—skin cancer	0.00702	0.0225	CcSEcCtD
Ciclesonide—Pharyngolaryngeal pain—Imiquimod—skin cancer	0.00538	0.0172	CcSEcCtD
Ciclesonide—Laryngeal pain—Imiquimod—skin cancer	0.00533	0.0171	CcSEcCtD
Ciclesonide—Gamma-glutamyltransferase increased—Vemurafenib—skin cancer	0.00518	0.0166	CcSEcCtD
Ciclesonide—Pain in extremity—Vismodegib—skin cancer	0.005	0.016	CcSEcCtD
Ciclesonide—Ulcer—Imiquimod—skin cancer	0.00384	0.0123	CcSEcCtD
Ciclesonide—Oral candidiasis—Temozolomide—skin cancer	0.00343	0.011	CcSEcCtD
Ciclesonide—Pain in extremity—Vemurafenib—skin cancer	0.00309	0.0099	CcSEcCtD
Ciclesonide—Swelling—Imiquimod—skin cancer	0.00299	0.00957	CcSEcCtD
Ciclesonide—Dysgeusia—Vismodegib—skin cancer	0.00295	0.00945	CcSEcCtD
Ciclesonide—Back pain—Vismodegib—skin cancer	0.00291	0.00934	CcSEcCtD
Ciclesonide—Nasal congestion—Imiquimod—skin cancer	0.00289	0.00927	CcSEcCtD
Ciclesonide—Ulcer—Bleomycin—skin cancer	0.00273	0.00874	CcSEcCtD
Ciclesonide—Gamma-glutamyltransferase increased—Temozolomide—skin cancer	0.00264	0.00847	CcSEcCtD
Ciclesonide—Pain in extremity—Imiquimod—skin cancer	0.00264	0.00845	CcSEcCtD
Ciclesonide—Arthralgia—Vismodegib—skin cancer	0.00256	0.00822	CcSEcCtD
Ciclesonide—Face oedema—Imiquimod—skin cancer	0.00254	0.00815	CcSEcCtD
Ciclesonide—Ulcer—Dactinomycin—skin cancer	0.00254	0.00815	CcSEcCtD
Ciclesonide—Wheezing—Bleomycin—skin cancer	0.00251	0.00803	CcSEcCtD
Ciclesonide—Infestation—Vemurafenib—skin cancer	0.00238	0.00763	CcSEcCtD
Ciclesonide—Infestation NOS—Vemurafenib—skin cancer	0.00238	0.00763	CcSEcCtD
Ciclesonide—Influenza—Imiquimod—skin cancer	0.00228	0.0073	CcSEcCtD
Ciclesonide—Oral candidiasis—Docetaxel—skin cancer	0.00228	0.0073	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00224	0.00718	CcSEcCtD
Ciclesonide—Bronchitis—Imiquimod—skin cancer	0.00219	0.00702	CcSEcCtD
Ciclesonide—Dyspepsia—Vismodegib—skin cancer	0.00216	0.00693	CcSEcCtD
Ciclesonide—Pharyngolaryngeal pain—Docetaxel—skin cancer	0.00214	0.00687	CcSEcCtD
Ciclesonide—Laryngeal pain—Docetaxel—skin cancer	0.00212	0.0068	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Vismodegib—skin cancer	0.00212	0.0068	CcSEcCtD
Ciclesonide—Fatigue—Vismodegib—skin cancer	0.00212	0.00679	CcSEcCtD
Ciclesonide—Ulcer—Fluorouracil—skin cancer	0.00212	0.00679	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Imiquimod—skin cancer	0.00212	0.00678	CcSEcCtD
Ciclesonide—Candida infection—Temozolomide—skin cancer	0.00208	0.00666	CcSEcCtD
Ciclesonide—Infestation—Imiquimod—skin cancer	0.00203	0.00651	CcSEcCtD
Ciclesonide—Infestation NOS—Imiquimod—skin cancer	0.00203	0.00651	CcSEcCtD
Ciclesonide—Urinary tract infection—Imiquimod—skin cancer	0.00197	0.00633	CcSEcCtD
Ciclesonide—Conjunctivitis—Imiquimod—skin cancer	0.00197	0.00633	CcSEcCtD
Ciclesonide—Mediastinal disorder—Vemurafenib—skin cancer	0.00193	0.00617	CcSEcCtD
Ciclesonide—Sinusitis—Imiquimod—skin cancer	0.00191	0.00611	CcSEcCtD
Ciclesonide—Ear pain—Temozolomide—skin cancer	0.00185	0.00593	CcSEcCtD
Ciclesonide—Haemoglobin—Imiquimod—skin cancer	0.00183	0.00587	CcSEcCtD
Ciclesonide—Rhinitis—Imiquimod—skin cancer	0.00183	0.00586	CcSEcCtD
Ciclesonide—Haemorrhage—Imiquimod—skin cancer	0.00182	0.00584	CcSEcCtD
Ciclesonide—Dysgeusia—Vemurafenib—skin cancer	0.00182	0.00584	CcSEcCtD
Ciclesonide—Pharyngitis—Imiquimod—skin cancer	0.00181	0.0058	CcSEcCtD
Ciclesonide—Back pain—Vemurafenib—skin cancer	0.0018	0.00577	CcSEcCtD
Ciclesonide—Rhinorrhoea—Docetaxel—skin cancer	0.00179	0.00572	CcSEcCtD
Ciclesonide—Gastroenteritis—Temozolomide—skin cancer	0.00178	0.00571	CcSEcCtD
Ciclesonide—Asthenia—Vismodegib—skin cancer	0.00176	0.00565	CcSEcCtD
Ciclesonide—Nasal congestion—Temozolomide—skin cancer	0.00173	0.00556	CcSEcCtD
Ciclesonide—Swelling—Fluorouracil—skin cancer	0.00165	0.00529	CcSEcCtD
Ciclesonide—Immune system disorder—Imiquimod—skin cancer	0.00165	0.00528	CcSEcCtD
Ciclesonide—Mediastinal disorder—Imiquimod—skin cancer	0.00164	0.00527	CcSEcCtD
Ciclesonide—Chest discomfort—Docetaxel—skin cancer	0.00164	0.00524	CcSEcCtD
Ciclesonide—Cough—Vemurafenib—skin cancer	0.00162	0.0052	CcSEcCtD
Ciclesonide—Bronchospasm—Bleomycin—skin cancer	0.00159	0.0051	CcSEcCtD
Ciclesonide—Oropharyngeal pain—Docetaxel—skin cancer	0.00159	0.0051	CcSEcCtD
Ciclesonide—Arthralgia—Vemurafenib—skin cancer	0.00158	0.00508	CcSEcCtD
Ciclesonide—Rash—Vismodegib—skin cancer	0.00155	0.00497	CcSEcCtD
Ciclesonide—Dermatitis—Vismodegib—skin cancer	0.00155	0.00496	CcSEcCtD
Ciclesonide—Back pain—Imiquimod—skin cancer	0.00154	0.00492	CcSEcCtD
Ciclesonide—Face oedema—Temozolomide—skin cancer	0.00152	0.00489	CcSEcCtD
Ciclesonide—Infection—Vemurafenib—skin cancer	0.00151	0.00484	CcSEcCtD
Ciclesonide—Nausea—Vismodegib—skin cancer	0.00146	0.00468	CcSEcCtD
Ciclesonide—Pneumonia—Bleomycin—skin cancer	0.00145	0.00465	CcSEcCtD
Ciclesonide—Angioedema—Imiquimod—skin cancer	0.00145	0.00465	CcSEcCtD
Ciclesonide—Palpitations—Imiquimod—skin cancer	0.0014	0.00449	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Temozolomide—skin cancer	0.00139	0.00446	CcSEcCtD
Ciclesonide—Cough—Imiquimod—skin cancer	0.00139	0.00444	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00138	0.00443	CcSEcCtD
Ciclesonide—Candida infection—Docetaxel—skin cancer	0.00138	0.00443	CcSEcCtD
Ciclesonide—Hypertension—Imiquimod—skin cancer	0.00137	0.00439	CcSEcCtD
Ciclesonide—Pneumonia—Dactinomycin—skin cancer	0.00135	0.00434	CcSEcCtD
Ciclesonide—Chest pain—Imiquimod—skin cancer	0.00135	0.00433	CcSEcCtD
Ciclesonide—Arthralgia—Imiquimod—skin cancer	0.00135	0.00433	CcSEcCtD
Ciclesonide—Dry mouth—Imiquimod—skin cancer	0.00132	0.00423	CcSEcCtD
Ciclesonide—Bronchitis—Temozolomide—skin cancer	0.00131	0.00421	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00131	0.0042	CcSEcCtD
Ciclesonide—Fatigue—Vemurafenib—skin cancer	0.00131	0.0042	CcSEcCtD
Ciclesonide—Haemoglobin—Bleomycin—skin cancer	0.0013	0.00417	CcSEcCtD
Ciclesonide—Nasopharyngitis—Fluorouracil—skin cancer	0.0013	0.00417	CcSEcCtD
Ciclesonide—Haemorrhage—Bleomycin—skin cancer	0.0013	0.00415	CcSEcCtD
Ciclesonide—Infection—Imiquimod—skin cancer	0.00129	0.00412	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Temozolomide—skin cancer	0.00127	0.00407	CcSEcCtD
Ciclesonide—Weight increased—Temozolomide—skin cancer	0.00124	0.00398	CcSEcCtD
Ciclesonide—Pneumonia—Temozolomide—skin cancer	0.00122	0.00392	CcSEcCtD
Ciclesonide—Infestation NOS—Temozolomide—skin cancer	0.00122	0.0039	CcSEcCtD
Ciclesonide—Infestation—Temozolomide—skin cancer	0.00122	0.0039	CcSEcCtD
Ciclesonide—Pharyngitis—Dactinomycin—skin cancer	0.0012	0.00384	CcSEcCtD
Ciclesonide—Swelling—Docetaxel—skin cancer	0.00119	0.00381	CcSEcCtD
Ciclesonide—Urinary tract infection—Temozolomide—skin cancer	0.00118	0.00379	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00118	0.00378	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00117	0.00375	CcSEcCtD
Ciclesonide—Dyspnoea—Imiquimod—skin cancer	0.00115	0.0037	CcSEcCtD
Ciclesonide—Sinusitis—Temozolomide—skin cancer	0.00114	0.00366	CcSEcCtD
Ciclesonide—Dyspepsia—Imiquimod—skin cancer	0.00114	0.00365	CcSEcCtD
Ciclesonide—Pneumonia—Fluorouracil—skin cancer	0.00113	0.00361	CcSEcCtD
Ciclesonide—Infestation NOS—Fluorouracil—skin cancer	0.00112	0.00359	CcSEcCtD
Ciclesonide—Infestation—Fluorouracil—skin cancer	0.00112	0.00359	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Imiquimod—skin cancer	0.00112	0.00358	CcSEcCtD
Ciclesonide—Fatigue—Imiquimod—skin cancer	0.00112	0.00358	CcSEcCtD
Ciclesonide—Haemoglobin—Temozolomide—skin cancer	0.0011	0.00352	CcSEcCtD
Ciclesonide—Haemorrhage—Temozolomide—skin cancer	0.00109	0.0035	CcSEcCtD
Ciclesonide—Conjunctivitis—Fluorouracil—skin cancer	0.00109	0.00349	CcSEcCtD
Ciclesonide—Urinary tract infection—Fluorouracil—skin cancer	0.00109	0.00349	CcSEcCtD
Ciclesonide—Asthenia—Vemurafenib—skin cancer	0.00109	0.00349	CcSEcCtD
Ciclesonide—Pharyngitis—Temozolomide—skin cancer	0.00108	0.00347	CcSEcCtD
Ciclesonide—Epistaxis—Fluorouracil—skin cancer	0.00106	0.00339	CcSEcCtD
Ciclesonide—Sinusitis—Fluorouracil—skin cancer	0.00105	0.00337	CcSEcCtD
Ciclesonide—Pain in extremity—Docetaxel—skin cancer	0.00105	0.00337	CcSEcCtD
Ciclesonide—Urticaria—Imiquimod—skin cancer	0.00103	0.0033	CcSEcCtD
Ciclesonide—Haemoglobin—Fluorouracil—skin cancer	0.00101	0.00324	CcSEcCtD
Ciclesonide—Rhinitis—Fluorouracil—skin cancer	0.00101	0.00323	CcSEcCtD
Ciclesonide—Haemorrhage—Fluorouracil—skin cancer	0.00101	0.00323	CcSEcCtD
Ciclesonide—Dizziness—Vemurafenib—skin cancer	0.001	0.00322	CcSEcCtD
Ciclesonide—Pharyngitis—Fluorouracil—skin cancer	0.000999	0.0032	CcSEcCtD
Ciclesonide—Immune system disorder—Temozolomide—skin cancer	0.000987	0.00316	CcSEcCtD
Ciclesonide—Mediastinal disorder—Temozolomide—skin cancer	0.000985	0.00316	CcSEcCtD
Ciclesonide—Cough—Bleomycin—skin cancer	0.000984	0.00315	CcSEcCtD
Ciclesonide—Chest pain—Bleomycin—skin cancer	0.00096	0.00308	CcSEcCtD
Ciclesonide—Rash—Vemurafenib—skin cancer	0.000958	0.00307	CcSEcCtD
Ciclesonide—Dermatitis—Vemurafenib—skin cancer	0.000957	0.00307	CcSEcCtD
Ciclesonide—Headache—Vemurafenib—skin cancer	0.000952	0.00305	CcSEcCtD
Ciclesonide—Nasopharyngitis—Docetaxel—skin cancer	0.000939	0.00301	CcSEcCtD
Ciclesonide—Dysgeusia—Temozolomide—skin cancer	0.000932	0.00298	CcSEcCtD
Ciclesonide—Asthenia—Imiquimod—skin cancer	0.000929	0.00298	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000926	0.00297	CcSEcCtD
Ciclesonide—Back pain—Temozolomide—skin cancer	0.00092	0.00295	CcSEcCtD
Ciclesonide—Infection—Bleomycin—skin cancer	0.000914	0.00293	CcSEcCtD
Ciclesonide—Nausea—Vemurafenib—skin cancer	0.000902	0.00289	CcSEcCtD
Ciclesonide—Bronchospasm—Docetaxel—skin cancer	0.000893	0.00286	CcSEcCtD
Ciclesonide—Angioedema—Temozolomide—skin cancer	0.000869	0.00278	CcSEcCtD
Ciclesonide—Dizziness—Imiquimod—skin cancer	0.000857	0.00274	CcSEcCtD
Ciclesonide—Infection—Dactinomycin—skin cancer	0.000853	0.00273	CcSEcCtD
Ciclesonide—Palpitations—Temozolomide—skin cancer	0.000841	0.00269	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000838	0.00269	CcSEcCtD
Ciclesonide—Cough—Temozolomide—skin cancer	0.00083	0.00266	CcSEcCtD
Ciclesonide—Weight increased—Docetaxel—skin cancer	0.000826	0.00265	CcSEcCtD
Ciclesonide—Hypertension—Temozolomide—skin cancer	0.000821	0.00263	CcSEcCtD
Ciclesonide—Dyspnoea—Bleomycin—skin cancer	0.000821	0.00263	CcSEcCtD
Ciclesonide—Rash—Imiquimod—skin cancer	0.000817	0.00262	CcSEcCtD
Ciclesonide—Dermatitis—Imiquimod—skin cancer	0.000816	0.00261	CcSEcCtD
Ciclesonide—Pneumonia—Docetaxel—skin cancer	0.000814	0.00261	CcSEcCtD
Ciclesonide—Headache—Imiquimod—skin cancer	0.000812	0.0026	CcSEcCtD
Ciclesonide—Arthralgia—Temozolomide—skin cancer	0.00081	0.00259	CcSEcCtD
Ciclesonide—Infestation NOS—Docetaxel—skin cancer	0.000809	0.00259	CcSEcCtD
Ciclesonide—Infestation—Docetaxel—skin cancer	0.000809	0.00259	CcSEcCtD
Ciclesonide—Dry mouth—Temozolomide—skin cancer	0.000792	0.00254	CcSEcCtD
Ciclesonide—Conjunctivitis—Docetaxel—skin cancer	0.000787	0.00252	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000782	0.00251	CcSEcCtD
Ciclesonide—Infection—Temozolomide—skin cancer	0.000771	0.00247	CcSEcCtD
Ciclesonide—Nausea—Imiquimod—skin cancer	0.000769	0.00247	CcSEcCtD
Ciclesonide—Epistaxis—Docetaxel—skin cancer	0.000764	0.00245	CcSEcCtD
Ciclesonide—Chest pain—Fluorouracil—skin cancer	0.000746	0.00239	CcSEcCtD
Ciclesonide—Fatigue—Dactinomycin—skin cancer	0.00074	0.00237	CcSEcCtD
Ciclesonide—Urticaria—Bleomycin—skin cancer	0.000731	0.00234	CcSEcCtD
Ciclesonide—Haemoglobin—Docetaxel—skin cancer	0.00073	0.00234	CcSEcCtD
Ciclesonide—Rhinitis—Docetaxel—skin cancer	0.000729	0.00233	CcSEcCtD
Ciclesonide—Haemorrhage—Docetaxel—skin cancer	0.000727	0.00233	CcSEcCtD
Ciclesonide—Pharyngitis—Docetaxel—skin cancer	0.000721	0.00231	CcSEcCtD
Ciclesonide—Infection—Fluorouracil—skin cancer	0.000711	0.00228	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000707	0.00227	CcSEcCtD
Ciclesonide—Dyspnoea—Temozolomide—skin cancer	0.000692	0.00222	CcSEcCtD
Ciclesonide—Dyspepsia—Temozolomide—skin cancer	0.000683	0.00219	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Temozolomide—skin cancer	0.00067	0.00215	CcSEcCtD
Ciclesonide—Fatigue—Temozolomide—skin cancer	0.000669	0.00214	CcSEcCtD
Ciclesonide—Asthenia—Bleomycin—skin cancer	0.00066	0.00212	CcSEcCtD
Ciclesonide—Immune system disorder—Docetaxel—skin cancer	0.000656	0.0021	CcSEcCtD
Ciclesonide—Mediastinal disorder—Docetaxel—skin cancer	0.000655	0.0021	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000652	0.00209	CcSEcCtD
Ciclesonide—Dyspnoea—Fluorouracil—skin cancer	0.000638	0.00204	CcSEcCtD
Ciclesonide—Dyspepsia—Fluorouracil—skin cancer	0.00063	0.00202	CcSEcCtD
Ciclesonide—Dysgeusia—Docetaxel—skin cancer	0.000619	0.00198	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000618	0.00198	CcSEcCtD
Ciclesonide—Urticaria—Temozolomide—skin cancer	0.000617	0.00198	CcSEcCtD
Ciclesonide—Asthenia—Dactinomycin—skin cancer	0.000616	0.00197	CcSEcCtD
Ciclesonide—Back pain—Docetaxel—skin cancer	0.000612	0.00196	CcSEcCtD
Ciclesonide—Rash—Bleomycin—skin cancer	0.00058	0.00186	CcSEcCtD
Ciclesonide—Dermatitis—Bleomycin—skin cancer	0.00058	0.00186	CcSEcCtD
Ciclesonide—Urticaria—Fluorouracil—skin cancer	0.000568	0.00182	CcSEcCtD
Ciclesonide—Palpitations—Docetaxel—skin cancer	0.000559	0.00179	CcSEcCtD
Ciclesonide—Asthenia—Temozolomide—skin cancer	0.000557	0.00178	CcSEcCtD
Ciclesonide—Cough—Docetaxel—skin cancer	0.000552	0.00177	CcSEcCtD
Ciclesonide—Nausea—Bleomycin—skin cancer	0.000547	0.00175	CcSEcCtD
Ciclesonide—Hypertension—Docetaxel—skin cancer	0.000546	0.00175	CcSEcCtD
Ciclesonide—Rash—Dactinomycin—skin cancer	0.000541	0.00173	CcSEcCtD
Ciclesonide—Arthralgia—Docetaxel—skin cancer	0.000539	0.00173	CcSEcCtD
Ciclesonide—Chest pain—Docetaxel—skin cancer	0.000539	0.00173	CcSEcCtD
Ciclesonide—Dry mouth—Docetaxel—skin cancer	0.000527	0.00169	CcSEcCtD
Ciclesonide—Dizziness—Temozolomide—skin cancer	0.000513	0.00164	CcSEcCtD
Ciclesonide—Infection—Docetaxel—skin cancer	0.000513	0.00164	CcSEcCtD
Ciclesonide—Nausea—Dactinomycin—skin cancer	0.00051	0.00163	CcSEcCtD
Ciclesonide—Rash—Temozolomide—skin cancer	0.000489	0.00157	CcSEcCtD
Ciclesonide—Dermatitis—Temozolomide—skin cancer	0.000489	0.00157	CcSEcCtD
Ciclesonide—Headache—Temozolomide—skin cancer	0.000486	0.00156	CcSEcCtD
Ciclesonide—Dizziness—Fluorouracil—skin cancer	0.000473	0.00152	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00047	0.00151	CcSEcCtD
Ciclesonide—Nausea—Temozolomide—skin cancer	0.000461	0.00148	CcSEcCtD
Ciclesonide—Dyspnoea—Docetaxel—skin cancer	0.00046	0.00147	CcSEcCtD
Ciclesonide—Dyspepsia—Docetaxel—skin cancer	0.000454	0.00146	CcSEcCtD
Ciclesonide—Rash—Fluorouracil—skin cancer	0.000451	0.00145	CcSEcCtD
Ciclesonide—CES1—neck—skin cancer	0.000451	0.119	CbGeAlD
Ciclesonide—Dermatitis—Fluorouracil—skin cancer	0.000451	0.00144	CcSEcCtD
Ciclesonide—Headache—Fluorouracil—skin cancer	0.000448	0.00144	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000446	0.00143	CcSEcCtD
Ciclesonide—Fatigue—Docetaxel—skin cancer	0.000445	0.00143	CcSEcCtD
Ciclesonide—Nausea—Fluorouracil—skin cancer	0.000425	0.00136	CcSEcCtD
Ciclesonide—Asthenia—Docetaxel—skin cancer	0.00037	0.00119	CcSEcCtD
Ciclesonide—NR3C1—nerve—skin cancer	0.000351	0.0923	CbGeAlD
Ciclesonide—Dizziness—Docetaxel—skin cancer	0.000341	0.00109	CcSEcCtD
Ciclesonide—Rash—Docetaxel—skin cancer	0.000326	0.00104	CcSEcCtD
Ciclesonide—Dermatitis—Docetaxel—skin cancer	0.000325	0.00104	CcSEcCtD
Ciclesonide—Headache—Docetaxel—skin cancer	0.000323	0.00104	CcSEcCtD
Ciclesonide—CES1—connective tissue—skin cancer	0.000323	0.085	CbGeAlD
Ciclesonide—Nausea—Docetaxel—skin cancer	0.000307	0.000983	CcSEcCtD
Ciclesonide—CES1—lymphoid tissue—skin cancer	0.000236	0.0621	CbGeAlD
Ciclesonide—CES1—female reproductive system—skin cancer	0.000228	0.0599	CbGeAlD
Ciclesonide—SERPINA6—female reproductive system—skin cancer	0.000228	0.0599	CbGeAlD
Ciclesonide—NR3C1—nipple—skin cancer	0.000199	0.0524	CbGeAlD
Ciclesonide—NR3C1—neck—skin cancer	0.000197	0.0519	CbGeAlD
Ciclesonide—CES1—head—skin cancer	0.00019	0.0501	CbGeAlD
Ciclesonide—SERPINA6—head—skin cancer	0.00019	0.05	CbGeAlD
Ciclesonide—NR3C1—connective tissue—skin cancer	0.000141	0.0372	CbGeAlD
Ciclesonide—NR3C1—epithelium—skin cancer	0.000134	0.0353	CbGeAlD
Ciclesonide—CES1—lymph node—skin cancer	0.000133	0.035	CbGeAlD
Ciclesonide—NR3C1—skin of body—skin cancer	0.000128	0.0336	CbGeAlD
Ciclesonide—NR3C1—mammalian vulva—skin cancer	0.000116	0.0306	CbGeAlD
Ciclesonide—NR3C1—lymphoid tissue—skin cancer	0.000103	0.0272	CbGeAlD
Ciclesonide—NR3C1—female reproductive system—skin cancer	9.97e-05	0.0262	CbGeAlD
Ciclesonide—NR3C1—head—skin cancer	8.33e-05	0.0219	CbGeAlD
Ciclesonide—CYP3A4—female reproductive system—skin cancer	7.54e-05	0.0198	CbGeAlD
Ciclesonide—CYP2D6—female reproductive system—skin cancer	7.42e-05	0.0195	CbGeAlD
Ciclesonide—CYP2D6—head—skin cancer	6.2e-05	0.0163	CbGeAlD
Ciclesonide—NR3C1—lymph node—skin cancer	5.83e-05	0.0153	CbGeAlD
